Cargando…
Two cases with fulminant type 1 diabetes that developed long after cessation of immune checkpoint inhibitor treatment
Various immune‐related adverse events (irAEs), including fulminant type 1 diabetes (FT1D), are known to be associated with immune checkpoint inhibitors (ICIs). We experienced two lung adenocarcinoma cases who developed fulminant type 1 diabetes long after discontinuation of ICI therapies. One, a 74‐...
Autores principales: | Hatayama, Satoko, Kodama, Shinjiro, Kawana, Yohei, Otake, Sonoko, Sato, Daiki, Horiuchi, Takahiro, Takahashi, Kei, Kaneko, Keizo, Imai, Junta, Katagiri, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340871/ https://www.ncbi.nlm.nih.gov/pubmed/35396830 http://dx.doi.org/10.1111/jdi.13807 |
Ejemplares similares
-
A case of fulminant type 1 diabetes and protein C deficiency complicated by deep vein thrombosis
por: Kohata, Masato, et al.
Publicado: (2023) -
Type 1 Diabetes Mellitus Associated with Nivolumab after Second SARS-CoV-2 Vaccination, Japan
por: Sato, Toshihiro, et al.
Publicado: (2022) -
Insulin-like growth factor-1 levels are associated with high comorbidity of metabolic disorders in obese subjects; a Japanese single-center, retrospective-study
por: Kubo, Haremaru, et al.
Publicado: (2022) -
Simultaneous Copy Number Losses within Multiple Subtelomeric Regions in Early-Onset Type2 Diabetes Mellitus
por: Kodama, Shinjiro, et al.
Publicado: (2014) -
Roles of FoxM1‐driven basal β‐cell proliferation in maintenance of β‐cell mass and glucose tolerance during adulthood
por: Kohata, Masato, et al.
Publicado: (2022)